{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:37Z","timestamp":1792590157523,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02746-y","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:44:08Z","timestamp":1784785448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Adriana","family":"Celesia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Aparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cisterna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Pacchiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Scupoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Donadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0141-2862","authenticated-orcid":false,"given":"Alessandra","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"2","key":"2746_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, et al. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology. 2022;163(2):386\u2013e4021.","journal-title":"Gastroenterology"},{"issue":"9","key":"2746_CR2","first-page":"851","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic Cancer: Rev JAMA. 2021;326(9):851\u201362.","journal-title":"Pancreatic Cancer: Rev JAMA"},{"issue":"5897","key":"2746_CR3","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801\u20136.","journal-title":"Science"},{"issue":"7540","key":"2746_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495\u2013501.","journal-title":"Nature"},{"issue":"2","key":"2746_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-23-0402","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells. Cancer Discov. 2024;14(2):362\u201379.","journal-title":"Cancer Discov"},{"issue":"6453","key":"2746_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aax3649","volume":"365","author":"S Boettcher","year":"2019","unstructured":"Boettcher S, et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science. 2019;365(6453):599\u2013604.","journal-title":"Science"},{"key":"2746_CR7","doi-asserted-by":"publisher","first-page":"e2200570","DOI":"10.1200\/PO.22.00570","volume":"7","author":"M Pan","year":"2023","unstructured":"Pan M, et al. TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma. JCO Precis Oncol. 2023;7:e2200570.","journal-title":"JCO Precis Oncol"},{"issue":"7568","key":"2746_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu J, et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 2015;525(7568):206\u201311.","journal-title":"Nature"},{"issue":"7","key":"2746_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.immuni.2025.06.005","volume":"58","author":"DB Mahat","year":"2025","unstructured":"Mahat DB, et al. Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity. 2025;58(7):1688\u2013e17059.","journal-title":"Immunity"},{"issue":"27","key":"2746_CR10","doi-asserted-by":"publisher","first-page":"eadu2339","DOI":"10.1126\/sciadv.adu2339","volume":"11","author":"L Urbach","year":"2025","unstructured":"Urbach L, et al. TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Sci Adv. 2025;11(27):eadu2339.","journal-title":"Sci Adv"},{"issue":"1","key":"2746_CR11","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/s41467-022-30481-7","volume":"13","author":"O Hassin","year":"2022","unstructured":"Hassin O, et al. Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients. Nat Commun. 2022;13(1):2800.","journal-title":"Nat Commun"},{"key":"2746_CR12","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt C, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211.","journal-title":"Redox Biol"},{"issue":"9","key":"2746_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai E, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26(9):1447\u201357.","journal-title":"Nat Cell Biol"},{"issue":"6486","key":"2746_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368(6486):85\u20139.","journal-title":"Science"},{"issue":"2","key":"2746_CR15","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.xcrm.2025.101928","volume":"6","author":"X Shen","year":"2025","unstructured":"Shen X, et al. Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Rep Med. 2025;6(2):101928.","journal-title":"Cell Rep Med"},{"key":"2746_CR16","doi-asserted-by":"publisher","first-page":"1417750","DOI":"10.3389\/fcell.2024.1417750","volume":"12","author":"J Xu","year":"2024","unstructured":"Xu J, et al. Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies. Front Cell Dev Biol. 2024;12:1417750.","journal-title":"Front Cell Dev Biol"},{"issue":"7545","key":"2746_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"8","key":"2746_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41580-025-00842-3","volume":"26","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases. Nat Rev Mol Cell Biol. 2025;26(8):600\u201314.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2746_CR19","doi-asserted-by":"publisher","first-page":"eadk1835","DOI":"10.1126\/sciadv.adk1835","volume":"10","author":"D Dibra","year":"2024","unstructured":"Dibra D, et al. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024;10(7):eadk1835.","journal-title":"Sci Adv"},{"issue":"1","key":"2746_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/febs.70223","volume":"293","author":"M Poles","year":"2026","unstructured":"Poles M, et al. Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells. FEBS J. 2026;293(1):156\u201374.","journal-title":"FEBS J"},{"issue":"1","key":"2746_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41419-025-08082-1","volume":"16","author":"F Danzi","year":"2025","unstructured":"Danzi F, et al. Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. Cell Death Dis. 2025;16(1):766.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2746_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285\u201396.","journal-title":"Cancer Cell"},{"issue":"3","key":"2746_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234\u201345.","journal-title":"Chem Biol"},{"issue":"6","key":"2746_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41557-019-0261-6","volume":"11","author":"E Llabani","year":"2019","unstructured":"Llabani E, et al. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis. Nat Chem. 2019;11(6):521\u201332.","journal-title":"Nat Chem"},{"issue":"5","key":"2746_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"12","key":"2746_CR26","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"2746_CR27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202503324","author":"Marion Russier","year":"2025","unstructured":"Russier M et al. Differential cell survival outcomes in response to diverse amino acid stress. Life Sci Alliance. 2025;8(11). https:\/\/doi.org\/10.26508\/lsa.202503324.","journal-title":"Life Sci Alliance"},{"issue":"5","key":"2746_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","volume":"82","author":"A Fiore","year":"2022","unstructured":"Fiore A, et al. Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling. Mol Cell. 2022;82(5):920\u2013e9327.","journal-title":"Mol Cell"},{"issue":"1","key":"2746_CR29","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V de Laat","year":"2024","unstructured":"de Laat V, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15(1):8540.","journal-title":"Nat Commun"},{"issue":"1","key":"2746_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbamcr.2014.10.003","volume":"1853","author":"C Fiorini","year":"2015","unstructured":"Fiorini C, et al. Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. Biochim Biophys Acta. 2015;1853(1):89\u2013100.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2746_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, et al. Role of Mitochondria in Ferroptosis. Mol Cell. 2019;73(2):354\u2013e3633.","journal-title":"Mol Cell"},{"issue":"1","key":"2746_CR32","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.xcrm.2024.101890","volume":"6","author":"O Hawsawi","year":"2025","unstructured":"Hawsawi O, et al. Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth. Cell Rep Med. 2025;6(1):101890.","journal-title":"Cell Rep Med"},{"key":"2746_CR33","doi-asserted-by":"publisher","unstructured":"Shi Q, Liu R, Chen L. Ferroptosis inhibitor ferrostatin\u20131 alleviates homocysteine\u2013induced ovarian granulosa cell injury by regulating TET activity and DNA methylation. Mol Med Rep. 2022;25(4). https:\/\/doi.org\/10.3892\/mmr.2022.12645.","DOI":"10.3892\/mmr.2022.12645"},{"key":"2746_CR34","doi-asserted-by":"publisher","first-page":"108929","DOI":"10.1016\/j.jnutbio.2021.108929","volume":"101","author":"RD Horniblow","year":"2022","unstructured":"Horniblow RD, et al. Iron-mediated epigenetic activation of NRF2 targets. J Nutr Biochem. 2022;101:108929.","journal-title":"J Nutr Biochem"},{"key":"2746_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.niox.2021.07.003","volume":"115","author":"T Homma","year":"2021","unstructured":"Homma T, et al. Nitric oxide protects against ferroptosis by aborting the lipid peroxidation chain reaction. Nitric Oxide. 2021;115:34\u201343.","journal-title":"Nitric Oxide"},{"key":"2746_CR36","doi-asserted-by":"publisher","first-page":"120257","DOI":"10.1016\/j.lfs.2021.120257","volume":"290","author":"Q He","year":"2022","unstructured":"He Q, et al. The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells. Life Sci. 2022;290:120257.","journal-title":"Life Sci"},{"key":"2746_CR37","doi-asserted-by":"publisher","first-page":"964034","DOI":"10.3389\/fcvm.2022.964034","volume":"9","author":"LL Zhang","year":"2022","unstructured":"Zhang LL, Tang RJ, Yang YJ. The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease. Front Cardiovasc Med. 2022;9:964034.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2746_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12920-022-01174-3","volume":"15","author":"Z Shokati Eshkiki","year":"2022","unstructured":"Shokati Eshkiki Z, et al. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Med Genomics. 2022;15(1):30.","journal-title":"BMC Med Genomics"},{"key":"2746_CR39","doi-asserted-by":"publisher","unstructured":"Nwosu ZC et al. Multidimensional analyses identify genes of high priority for pancreatic cancer research. JCI Insight. 2025;10(4). https:\/\/doi.org\/10.1172\/jci.insight.174264.","DOI":"10.1172\/jci.insight.174264"},{"issue":"8","key":"2746_CR40","doi-asserted-by":"publisher","first-page":"108767","DOI":"10.1016\/j.celrep.2021.108767","volume":"34","author":"X Song","year":"2021","unstructured":"Song X, et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis. Cell Rep. 2021;34(8):108767.","journal-title":"Cell Rep"},{"issue":"4","key":"2746_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00432-024-05748-9","volume":"150","author":"W Shi","year":"2024","unstructured":"Shi W, et al. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1\/JNK pathway. J Cancer Res Clin Oncol. 2024;150(4):218.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"2746_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41419-021-04008-9","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu Q, et al. GPX4 and vitamin E cooperatively protect hematopoietic stem and progenitor cells from lipid peroxidation and ferroptosis. Cell Death Dis. 2021;12(7):706.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2746_CR43","doi-asserted-by":"publisher","first-page":"e0201369","DOI":"10.1371\/journal.pone.0201369","volume":"13","author":"A Hinman","year":"2018","unstructured":"Hinman A, et al. Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS ONE. 2018;13(8):e0201369.","journal-title":"PLoS ONE"},{"issue":"1","key":"2746_CR44","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/s41467-024-48307-z","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, et al. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun. 2024;15(1):4296.","journal-title":"Nat Commun"},{"issue":"6","key":"2746_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-024-06789-1","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma. Cell Death Dis. 2024;15(6):395.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2746_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"2746_CR47","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1038\/sj.onc.1208419","volume":"24","author":"VJ Bykov","year":"2005","unstructured":"Bykov VJ, et al. PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis. Oncogene. 2005;24(21):3484\u201391.","journal-title":"Oncogene"},{"key":"2746_CR48","doi-asserted-by":"publisher","unstructured":"Kemp SB et al. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Life Sci Alliance. 2021;4(6). https:\/\/doi.org\/10.26508\/lsa.202000935.","DOI":"10.26508\/lsa.202000935"},{"issue":"11","key":"2746_CR49","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s43018-022-00463-1","volume":"3","author":"CJ Halbrook","year":"2022","unstructured":"Halbrook CJ, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nat Cancer. 2022;3(11):1386\u2013403.","journal-title":"Nat Cancer"},{"issue":"5","key":"2746_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. Cell Chem Biol. 2019;26(5):623\u2013e6339.","journal-title":"Cell Chem Biol"},{"issue":"4","key":"2746_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","volume":"3","author":"H Alborzinia","year":"2022","unstructured":"Alborzinia H, et al. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat Cancer. 2022;3(4):471\u201385.","journal-title":"Nat Cancer"},{"issue":"3","key":"2746_CR52","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41418-024-01407-1","volume":"32","author":"C Liu","year":"2025","unstructured":"Liu C, et al. The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma. Cell Death Differ. 2025;32(3):506\u201320.","journal-title":"Cell Death Differ"},{"issue":"43","key":"2746_CR53","doi-asserted-by":"publisher","first-page":"111433","DOI":"10.3748\/wjg.v31.i43.111433","volume":"31","author":"V Tonini","year":"2025","unstructured":"Tonini V, Zanni M. Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol. 2025;31(43):111433.","journal-title":"World J Gastroenterol"},{"key":"2746_CR54","doi-asserted-by":"publisher","first-page":"1148192","DOI":"10.3389\/fgene.2023.1148192","volume":"14","author":"M Corazzari","year":"2023","unstructured":"Corazzari M, Collavin L. Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management? Front Genet. 2023;14:1148192.","journal-title":"Front Genet"},{"key":"2746_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","volume":"133","author":"R Kang","year":"2019","unstructured":"Kang R, Kroemer G, Tang D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med. 2019;133:162\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"64","key":"2746_CR56","first-page":"pe70162","volume":"2025","author":"K Zhou","year":"2020","unstructured":"Zhou K, et al. Pancreatic Cancer: Pathogenesis and Clinical Studies. MedComm. 2020;2025(64):pe70162.","journal-title":"MedComm"},{"issue":"6","key":"2746_CR57","doi-asserted-by":"publisher","first-page":"115774","DOI":"10.1016\/j.celrep.2025.115774","volume":"44","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. GCLM lactylation mediated by ACAT2 promotes ferroptosis resistance in KRAS(G12D)-mutant cancer. Cell Rep. 2025;44(6):115774.","journal-title":"Cell Rep"},{"issue":"3","key":"2746_CR58","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1097\/MPA.0000000000002426","volume":"54","author":"H Zhao","year":"2025","unstructured":"Zhao H, et al. Oncogenic KRAS Promotes Ferroptosis in Pancreatic Cancer Through Regulation of the Fosl1-Tfrc Axis. Pancreas. 2025;54(3):e235\u201345.","journal-title":"Pancreas"},{"issue":"12","key":"2746_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"11","key":"2746_CR60","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292\u2013320.","journal-title":"Nat Protoc"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02746-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:03:09Z","timestamp":1792587789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02746-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"248"}}